FDA approves new Moderna COVID-19 vaccine

Moderna announced that the Food and Drug Administration has given the green light to its updated COVID-19 vaccine for adults over 65 and individuals aged 12 to 64 with certain underlying health conditions that increase their risk of severe infection. This approval marks the first of its kind after the FDA implemented stricter standards for COVID vaccines, necessitating additional research before authorizing revised shots for healthy adults under 65.